Mid career · publishing since 2014Rising activity
Glioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismATP Synthase and ATPases ResearchEpigenetics and DNA MethylationFerrocene Chemistry and Applications
Publications
162
Citations
1,313
Est. group size
~28
Recurring co-author estimate
Active years
13
Publishing since 2014
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 1,313p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 29.0p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~28 · 6% small-team papers (≤3 authors) · across 17 venues
Publication cadence
Publications per year over the last 10 years — averaging 29.0/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- ZFTA–RELA ependymomas make itaconate to epigenetically drive fusion expression
Nature · 2026
- A Seat at the Table Requires an Invitation: Language-Based Inequities in Family Participation
Hospital Pediatrics · 2026
- Tamoxifen induces PI3K activation in uterine cancer
Nature Genetics · 2025
- ATRT-02. Update to the descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States
Neuro-Oncology Pediatrics · 2025
- MDB-24. Integrated metabolic and epigenetic therapies for Group-3 Medulloblastomas
Neuro-Oncology Pediatrics · 2025
- Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020
The Oncologist · 2023
- Data from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Figure from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Figure from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Table from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Data from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Figure from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Figure from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Figure from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
- Supplementary Figure from A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
2023
Publishes in
- Cancer Research×5
- Cancer Cell×3
- Figshare×3
- Cancer Discovery×2
- Proceedings of the National Academy of Sciences×2
Similar researchers
By research-topic overlap
- Sriram Venneti
Medicine · University of Michigan
- Ziyun Xia
Medicine · University of Michigan
- Mateus Mota
Medicine · University of Michigan
- Tingting Qin
Medicine · University of Michigan
- Andrea Franson
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile